When ATH:
N04BA02
Pharmacological action
An inhibitor of the peripheral dopa decarboxylase. In combination with levodopa reduces the formation of dopamine in peripheral tissues and enhancing amount of levodopa, entering the CNS. Является также ингибитором периферической декарбоксилазы окситриптана – предшественника серотонина. Do not cross the BBB.
Pharmacokinetics
Data for farmakokinetike carbidopa limited.
Testimony
In combination with levodopa: Parkinson's disease, Parkinson's syndrome (except parkinsonism, drug-induced, in particular neuroleptics).
Dosage regimen
When applied in combination with carbidopa levodopa in the ratio 1:4 or 1:10 daily dose of carbidopa is 75-200 mg in a few simple steps.
Side effect
CNS: редко – самопроизвольные движения, sleep disorders, ažitaciâ, dizziness, depression.
Cardio-vascular system: rarely - orthostatic hypotension, Arrhythmia.
From the digestive system: rarely - nausea, vomiting, anorexia, epigastric pain, dysphagia, ulcerogenic action (in predisposed patients).
From the hematopoietic system: a rare - thrombocytopenia.
The aforementioned side effects encountered in applying combined with carbidopa levodopa.
Contraindications
Expressions of the liver, kidney, cardiovascular and / or endocrine, severe psychosis, zakrыtougolynaya glaucoma, melanoma, childhood, hypersensitivity to karbidope.
Pregnancy and breast-feeding
If necessary, use of carbidopa in combination with levodopa during pregnancy and lactation should carefully weigh the potential benefits for the mother and the potential risk to the fetus or infant.
Cautions
It is used in combination with levodopa.
The use of carbidopa in combination with levodopa is contraindicated during treatment with MAO inhibitors (except MAO-B inhibitors in low doses).
Effects on ability to drive vehicles and management mechanisms
During the period of carbidopa in combination with levodopa should avoid activities, at that require high concentration and speed of psychomotor reactions.
Drug Interactions
Combination with levodopa allows you to reduce the dose and severity of side effects last, especially nausea, vomiting, Arrhythmia. Along with this there may be a tendency to early development of dyskinesias and mental disorders, associated with the action of levodopa.
While applying the combination of carbidopa with levodopa and iron sulfate may reduce the bioavailability of carbidopa and levodopa.
This site uses cookies and services to collect technical data from visitors to ensure performance and improve the quality of service.. By continuing to use our site, you automatically agree to the use of these technologies.
Read More